OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase
Vera Battini, Robbert P. van Manen, Michele Gringeri, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Vera Battini, Robbert P. van Manen, Michele Gringeri, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Showing 13 citing articles:
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, et al.
Frontiers in Drug Safety and Regulation (2024) Vol. 3
Open Access | Times Cited: 42
Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, et al.
Frontiers in Drug Safety and Regulation (2024) Vol. 3
Open Access | Times Cited: 42
Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database
Jianxing Zhou, You Zheng, Baohua Xu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Jianxing Zhou, You Zheng, Baohua Xu, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Drug Repurposing Using FDA Adverse Event Reporting System (FAERS) Database
Robert Morris, Rahinatu Ali, Feng Cheng
Current Drug Targets (2024) Vol. 25, Iss. 7, pp. 454-464
Closed Access | Times Cited: 9
Robert Morris, Rahinatu Ali, Feng Cheng
Current Drug Targets (2024) Vol. 25, Iss. 7, pp. 454-464
Closed Access | Times Cited: 9
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access | Times Cited: 1
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access | Times Cited: 1
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
Silvia Tempia Valenta, Alba Nicastri, Federica Perazza, et al.
Current Treatment Options in Psychiatry (2024)
Closed Access | Times Cited: 6
Silvia Tempia Valenta, Alba Nicastri, Federica Perazza, et al.
Current Treatment Options in Psychiatry (2024)
Closed Access | Times Cited: 6
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression
Vera Battini, Giovanna Cirnigliaro, Rodolfo Leuzzi, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 15
Vera Battini, Giovanna Cirnigliaro, Rodolfo Leuzzi, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 15
Promising new pharmacological targets for depression: The search for efficacy
Lucila Emiko Tsugiyama, Ruan Carlos Macêdo de Moraes, Yaslle Andrade Cavalcante Moraes, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103804-103804
Closed Access | Times Cited: 8
Lucila Emiko Tsugiyama, Ruan Carlos Macêdo de Moraes, Yaslle Andrade Cavalcante Moraes, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 12, pp. 103804-103804
Closed Access | Times Cited: 8
The Optimal Dosage and Duration of Metformin for Prevention and Treatment of Antipsychotic-Induced Weight Gain: An Updated Systematic Review and Meta-Analysis
Tzu‐Rong Peng, Jou-An Chen, Jen‐Ai Lee, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
Tzu‐Rong Peng, Jou-An Chen, Jen‐Ai Lee, et al.
Schizophrenia Bulletin (2024)
Closed Access | Times Cited: 1
Recommendations for the selection of nucleoside analogues as antihuman herpesvirus drugs: a real-world analysis of reported cases from the FDA adverse event reporting system
Caixia Gao, Xiaomei Dong, Jilei Zhang, et al.
Expert Opinion on Drug Safety (2024), pp. 1-15
Open Access
Caixia Gao, Xiaomei Dong, Jilei Zhang, et al.
Expert Opinion on Drug Safety (2024), pp. 1-15
Open Access
Effect of GLP-1 receptor agonists on obesity in patients with severe mental illness: A state hospital case series of clozapine-treated patients
Syed Sadat Ali, Narges Ghodsimaab, Matthew Rusling, et al.
Psychiatry Research Case Reports (2024) Vol. 3, Iss. 2, pp. 100231-100231
Open Access
Syed Sadat Ali, Narges Ghodsimaab, Matthew Rusling, et al.
Psychiatry Research Case Reports (2024) Vol. 3, Iss. 2, pp. 100231-100231
Open Access
Fracture events associated with GLP-1 receptor agonists in FDA adverse events reporting system
Yao Xiao, Min Zhou, Wenfeng Xiao
Acta Diabetologica (2024)
Closed Access
Yao Xiao, Min Zhou, Wenfeng Xiao
Acta Diabetologica (2024)
Closed Access
Mitochondrial DNA copy number as a mediator of the relationship between insulin resistance and cognitive function in patients with euthymic bipolar disorder
Tsung‐Han Tsai, Cheng Ying Wu, Cheng‐Chen Chang, et al.
The Kaohsiung Journal of Medical Sciences (2024)
Open Access
Tsung‐Han Tsai, Cheng Ying Wu, Cheng‐Chen Chang, et al.
The Kaohsiung Journal of Medical Sciences (2024)
Open Access
